Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, shared a recent article by Tyler B. Sandahl on X:

“Great to see in JCO Oncology Practice – Mayo experience with outpatient teclistamab step-up dosing in Multiple Myeloma.

This is where the field is headed, and impressive to see how quickly Mayo Myeloma campuses moved there and how much this time toxicity for patients.”

Title: Real-World Safety and Health Care Resource Utilization of Teclistamab Under an Outpatient Model for Step-Up Dosing Administration

Authors: Tyler B. Sandahl, Scott A. Soefje, Rafael Fonseca, Sikander Ailawadhi, Ricardo Parrondo, Dee Lin, Bingcao Wu, Ediz S. Calay, Eli Silvert, Nina Kim, Corinne Carpenter, Tyler E. Wagner, Jessica Fowler, Laura Hester, Nivedita Rangarajan, Karthik Murugadoss, Alexander Marshall, Patrick Stoy, Dina Gifkins, Yi Li and Shaji Kumar

Outpatient teclistamab step-up dosing in Multiple Myeloma

Rahul Banerjee is an assistant professor at Fred Hutchinson Cancer Center at the University of Washington. He completed his residency at the University of Pennsylvania health system.

He completed his fellowship in haematology and oncology from the University of California, San Francisco. He has authored over 70 peer-reviewed publications. His clinical interests include multiple myeloma.

More posts featuring Rahul Banerjee.